HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of bioactive constituents in the Traditional Chinese Medicinal formula Si-Wu-Tang on Nrf2 signaling and neoplastic cellular transformation.

AbstractBACKGROUND:
The nuclear factor erythroid 2-related factor 2 (Nrf2) is a potential molecular target for cancer chemoprevention. Si-Wu-Tang (SWT), a popular traditional Chinese medicine for women's health, was reported with a novel activity of cancer prevention.
PURPOSE:
The present study was aimed to identify the bioactive constituents in SWT responsible for the Nrf2 activating and cancer preventive activity and explore the pharmacological mechanisms.
METHODS:
Nine compounds detectable from various batches of SWT were ranked using in silico molecular docking based on their ability to interfere the forming of Nrf2-Keap1 complex. The predicted Nrf2 activating effect was validated using the antioxidant response element (ARE) luciferase reporter assay and quantitative RT-PCR analysis for select Nrf2 regulated genes Hmox1, Nqo1 and Slc7a11. The antimutagenic activity of the compounds were determined by the Ames test. The chemopreventive activity of these compounds were assessed on EGF-induced neoplastic transformation of JB6 P+ cells, an established non-cancerous murine epidermal model for studying tumor promotion and identifying cancer preventive agents. These compounds were further characterized using luciferase reporter assay on EGF-induced activation of AP-1, a known transcription factor mediating carcinogenesis.
RESULTS:
Three of the nine compounds predicted as Nrf2 activators by molecular docking, gallic acid (GA), Z-liguistilide (LIG), and senkyunolide A (SA), were confirmed with highest potency of increasing the Nrf2/ARE promoter activity and upregulating the expression of Hmox1, Nqo1 and Slc7a11. In addition, GA, LIG and SA exhibited an antimutagenic activity against the direct mutagen 2-nitrofluorene while no mutagenic effects were observed at the same time in Ames test. At nontoxic concentrations, GA, LIG, and SA inhibited EGF-induced neoplastic transformation of JB6 P+ cells. Combined treatment of GA, LIG and SA, in the same ratio as detected in SWT, showed enhanced effect against JB6 transformation compared with that of the single compound alone. GA, LIG and SA, alone or in combination, suppressed EGF-induced activation of AP-1.
CONCLUSION:
We identified three bioactive constituents in SWT responsible for the Nrf2 activating and cancer preventive activity. This study provides evidence supporting novel molecular basis of SWT in cancer prevention.
AuthorsMandy M Liu, Kevin M Huang, Li Qian, Payal Chatterjee, Suhui Zhang, Rui Li, Su Zhou, Zhijun Wang, Yun Luo, Ying Huang
JournalPhytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine) Vol. 40 Pg. 1-9 (Feb 01 2018) ISSN: 1618-095X [Electronic] Germany
PMID29496161 (Publication Type: Journal Article)
CopyrightCopyright © 2017 Elsevier GmbH. All rights reserved.
Chemical References
  • Anticarcinogenic Agents
  • Drugs, Chinese Herbal
  • NF-E2-Related Factor 2
  • Transcription Factor AP-1
  • si-wu-tang
  • Heme Oxygenase-1
  • NAD(P)H Dehydrogenase (Quinone)
  • NQO1 protein, human
Topics
  • Animals
  • Anticarcinogenic Agents (chemistry, pharmacology)
  • Antioxidant Response Elements (drug effects, genetics)
  • Cell Line
  • Cell Transformation, Neoplastic (drug effects, genetics)
  • Drugs, Chinese Herbal (chemistry, pharmacology)
  • Gene Expression Regulation (drug effects)
  • Heme Oxygenase-1
  • Humans
  • Medicine, Chinese Traditional
  • Mice
  • Molecular Docking Simulation
  • NAD(P)H Dehydrogenase (Quinone) (genetics, metabolism)
  • NF-E2-Related Factor 2 (metabolism)
  • Signal Transduction (drug effects)
  • Transcription Factor AP-1 (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: